Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book Deals 20 d ago also on LGND
Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital Markets 29 d ago also on LGND